EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns

Muna Barakat, Samar Thiab, Lujain F. Alzaghari, Shaymaa B. Abdulrazzaq, Eliza Hasen, Sara Feras Abuarab, Lara Nasereddin, Amin Omar, Yasmeen Barakat, Dinesh Kumar Chellappan, Mohammad A.A. Al-Najjar

Phytomedicine Plus · 2025-11 · 5 (4) · 100876

DOI: 10.1016/j.phyplu.2025.100876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine Plus, 2025-11. Verfasst von Muna Barakat und 10 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis has long been esteemed for its analgesic, anti-inflammatory, and sedative characteristics. Ancient people such as the Egyptians, Greeks, and Chinese acknowledged the curative value of their medicinal practices. The identification of the endocannabinoid system, which engages with cannabis phytochemicals, has elucidated the mechanisms by which cannabis influences the human immune system, including the central nervous system. Cannabis and its bioactive components, particularly cannabinoids such as delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have garnered substantial interest for their potential therapeutic effects. This review comprehensively examines the interactions between cannabis and the immune system, focusing on immune cell function, clinical evidence, molecular mechanisms, and ongoing controversies. Cannabinoids modulate immune responses by interacting with cannabinoid receptors (CB1 and CB2) expressed on various immune cells. THC generally exhibits immunosuppressive properties beneficial in conditions such as autoimmune diseases, whereas CBD shows anti-inflammatory effects without broadly suppressing immune function. The review also highlights the complex impact of cannabinoids on T lymphocytes, B lymphocytes, macrophages, dendritic cells, and natural killer cells, influencing cytokine production and immune signaling pathways. Clinical studies suggest that cannabinoids may alleviate symptoms of multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus, although their long-term impact on immune competence remains uncertain. Epidemiological studies indicate that chronic cannabis use may alter immune responses, with both beneficial and adverse effects. The review underscores the need for more extensive research to understand the dose-dependent immunomodulatory effects of cannabinoids and their potential for developing personalized therapeutic strategies. Emerging trends in cannabinoid research and the potential for cannabis-based therapies in immune-related diseases are also discussed, highlighting the promise and challenges in this evolving field.

Zitieren

APA

Barakat, M., Thiab, S., Alzaghari, L. F., Abdulrazzaq, S. B., Hasen, E., Abuarab, S. F., Nasereddin, L., Omar, A., Barakat, Y., Chellappan, D. K., & Al-Najjar, M. A. (2025). Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns. Phytomedicine Plus, 5(4), 100876. https://doi.org/10.1016/j.phyplu.2025.100876

Vancouver

Barakat M, Thiab S, Alzaghari LF, Abdulrazzaq SB, Hasen E, Abuarab SF, et al. Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns. Phytomedicine Plus. 2025;5(4):100876. doi:10.1016/j.phyplu.2025.100876

BibTeX
@article{Barakat2025,
  author = {Barakat, Muna and Thiab, Samar and Alzaghari, Lujain F. and Abdulrazzaq, Shaymaa B. and Hasen, Eliza and Abuarab, Sara Feras and Nasereddin, Lara and Omar, Amin and Barakat, Yasmeen and Chellappan, Dinesh Kumar and Al-Najjar, Mohammad A.A.},
  title = {Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns},
  journal = {Phytomedicine Plus},
  year = {2025},
  volume = {5},
  number = {4},
  pages = {100876},
  doi = {10.1016/j.phyplu.2025.100876}
}
Kostenlos starten →